HALOPERIDOL DECANOATE
ANTIPSYCHOTICS · SCHIZOPHRENIA
SAGENT PHARMACE
Drug class
Butyrophenones
Butyrophenones are a distinct chemical class of first-generation neuroleptic agents that primarily act as potent antagonists at postsynaptic dopamine D2 receptors in the central nervous system. Read more about Butyrophenones
48 drugs in this class 40 manufacturers
Drugs in Butyrophenones
HALOPERIDOL LACTATE
ANTIPSYCHOTICS · SCHIZOPHRENIA ·+2
SILARX/LANNETT
HALOPERIDOL LACTATE
ANTIPSYCHOTICS · SCHIZOPHRENIA ·+2
FRESENIUS KABI
HALOPERIDOL LACTATE
ANTIPSYCHOTICS · SCHIZOPHRENIA ·+2
Hikma Pharmaceuticals USA
HALOPERIDOL DECANOATE
ANTIPSYCHOTICS · SCHIZOPHRENIA
Pfizer Laboratories
CAPLYTA (lumateperone tosylate)
ANTIPSYCHOTICS · SCHIZOPHRENIA ·+2
INTRA-CELLULAR
HALOPERIDOL
ANTIPSYCHOTICS · SCHIZOPHRENIA ·+2
Upsher-Smith Laboratories
HALOPERIDOL
ANTIPSYCHOTICS · SCHIZOPHRENIA ·+2
Major Pharamceuticals
HALOPERIDOL
ANTIPSYCHOTICS · SCHIZOPHRENIA ·+2
GSK Consumer Healthcare
Filter & compare in the drug finder →
Opens the drug finder with Butyrophenones preselected. Add indication or manufacturer filters there.
Butyrophenones are a distinct chemical class of first-generation neuroleptic agents that primarily act as potent antagonists at postsynaptic dopamine D2 receptors in the central nervous system.
By blocking dopaminergic signaling in mesolimbic pathways and the chemoreceptor trigger zone, these medications reduce psychotic symptoms and exert antiemetic and sedative effects.
Clinically, drugs within this class—most notably haloperidol and droperidol—are widely utilized in psychiatry and acute care for the management of schizophrenia, acute psychotic agitation, Tourette syndrome, and postoperative nausea and vomiting.
-
fda.gov
Butyrophenones are a distinct chemical class of first-generation neuroleptic agents that primarily act as potent antagonists at postsynaptic dopamine D2 receptors in the central nervous system
-
nih.gov
Butyrophenones are a distinct chemical class of first-generation neuroleptic agents that primarily act as potent antagonists at postsynaptic dopamine D2 receptors in the central nervous system By blocking dopaminergic signaling in mesolimbic pathways and the chemoreceptor trigger zone, these medications reduce psychotic symptoms and exert antiemetic and sedative effects Clinically, drugs within this class—most notably haloperidol and droperidol—are widely utilized in psychiatry and acute care fo...
-
nih.gov
Butyrophenones are a distinct chemical class of first-generation neuroleptic agents that primarily act as potent antagonists at postsynaptic dopamine D2 receptors in the central nervous system Clinically, drugs within this class—most notably haloperidol and droperidol—are widely utilized in psychiatry and acute care for the management of schizophrenia, acute psychotic agitation, Tourette syndrome, and postoperative nausea and vomiting
-
nih.gov
By blocking dopaminergic signaling in mesolimbic pathways and the chemoreceptor trigger zone, these medications reduce psychotic symptoms and exert antiemetic and sedative effects
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.